The first Health Technology Assessment (HTA) stakeholder meeting, organized by DRIVE-AB Work Package 2 (creating and testing economic models), was held on 14 June 2015 during the International HTA Conference in Oslo, Norway. The purpose of this meeting was to educate HTA stakeholders from around the world about DRIVE-AB, and to learn from them their views on how to implement new economic models into the assessment of novel antibiotics, and how to bring these novel antibiotics to market with alternative trial designs.
Slide set by Work Package 2 co-leader John-Arne Røttingen: “DRIVE-AB: Driving Re-Investment in R&D and Responsible Antibiotic Use“.